BIOCAD has become an industrial partner of the “Vector” development of the vaccine from COVID-19

Biotechnological company BIOCAD has signed an agreement with a scientific center “Vector” on joint work on a vaccine based on the rVSV against COVID-19. The process of vaccine development has entered the final stage, the vaccine showed promise in tests on laboratory animals, including non human primates.

Under the agreement, biotechnology company BIOCAD bears the costs and organization of clinical trials rVSV vaccine, development of technology of production of preparation and production. Now to work on the vaccines allocated to three research groups, which employ more than 80 people of different specializations: genetic engineering and Virology to chemistry and bioinformatics.

“We have long been in scientific collaboration with Novosibirsk “Vector”, — said Dmitry Morozov, General Director of the biotechnological company BIOCAD, and now act as an industrial partner of the project on the development of the rVSV vaccine. We are pleased to provide our partners with industrial production, when will the clinical studies. In my opinion, today we should unite their intellectual efforts.”

Currently BIOCAD is working on developing mRNA-vaccine against coronavirus (SARS-CoV-2). Development will be based on the previous work to create oncovin. In late March the company agreed with the Ministry of healthcare of RF and the program of preclinical and first-phase clinical development of vaccines against coronavirus. The beginning of clinical trials is expected in 4-5 months.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]